Skip to main page content
U.S. flag

An official website of the United States government

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Search Results

34 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Induction of potent and long-lasting CD4 and CD8 T-cell responses against hepatitis C virus by immunization with viral antigens plus poly(I:C) and anti-CD40.
Zabaleta A, Arribillaga L, Llopiz D, Dotor J, Lasarte JJ, Prieto J, Borrás-Cuesta F, Esteban JI, Quer J, Vayreda F, Sarobe P. Zabaleta A, et al. Among authors: arribillaga l. Antiviral Res. 2007 Apr;74(1):25-35. doi: 10.1016/j.antiviral.2007.01.001. Epub 2007 Jan 22. Antiviral Res. 2007. PMID: 17275104 Free article.
Immunization against hepatitis C virus with a fusion protein containing the extra domain A from fibronectin and the hepatitis C virus NS3 protein.
Mansilla C, Gorraiz M, Martinez M, Casares N, Arribillaga L, Rudilla F, Echeverria I, Riezu-Boj JI, Sarobe P, Borrás-Cuesta F, Prieto J, Lasarte JJ. Mansilla C, et al. Among authors: arribillaga l. J Hepatol. 2009 Sep;51(3):520-7. doi: 10.1016/j.jhep.2009.06.005. Epub 2009 Jun 23. J Hepatol. 2009. PMID: 19596480 Free article.
CD4+/CD25+ regulatory cells inhibit activation of tumor-primed CD4+ T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination.
Casares N, Arribillaga L, Sarobe P, Dotor J, Lopez-Diaz de Cerio A, Melero I, Prieto J, Borrás-Cuesta F, Lasarte JJ. Casares N, et al. Among authors: arribillaga l. J Immunol. 2003 Dec 1;171(11):5931-9. doi: 10.4049/jimmunol.171.11.5931. J Immunol. 2003. PMID: 14634104 Free article.
34 results